Scanadu is Preparing Consumer Self-Test Device for Review by the FDA as Part of Its Mission to Enable Patients to Monitor Their Health without the Need for Clinical Pathology Laboratory Tests

Scanadu’s device is called the ScanaFlo and is designed to collect biometric data from consumers using a variety of methods, including urine specimens Now gathering study data needed to launch a review by the Food and Drug Administration (FDA) is a low-cost lab urinalysis device that returns results via a smartphone for conditions such as pregnancy and diabetes. More significant for pathologists and clinical laboratory executives, this handy point-of-care device is capable of doing tests for...

New iPhone App Allows Consumers to Test Their Urine on the Go for as Many as 25 Different Diseases

Pathologists and clinical laboratory managers may want to learn more about the UCheck mobile app developed by Biosense Technologies   Developers of a new iPhone application claim their app can analyze a urine specimen for up to 25 different diseases. This mobile app is a deliberate attempt to give consumers the ability to perform diagnostic tests that would normally be run in a full-scale clinical laboratory. Pathologists and clinical biochemists will want to visit the website of Biosense...

Laboratory Transforms Manual Urinalysis with Automation and More

Pre-analytical products, automated systems, and Lean Six Sigma combined to improve outcomes In today’s era of automation and Lean Six Sigma processes in laboratory medicine, the manual urinalysis test may be ready for a major makeover. Such a development would be welcome because, in the typical American hospital, the clinical laboratory performs an average of 120 urinalyses per day. Some clinical laboratory managers consider it counterintuitive that—during a period of automation and...
;